Genmab Cash Flow from Operating Activities 2010-2025 | GNMSF
Genmab cash flow from operating activities for the twelve months ending March 31, 2025 was $2.596B, a 2.41% decline year-over-year.
- Genmab annual cash flow from operating activities for 2024 was $1.127B, a 5.15% increase from 2023.
- Genmab annual cash flow from operating activities for 2023 was $1.072B, a 93.45% increase from 2022.
- Genmab annual cash flow from operating activities for 2022 was $0.554B, a 56.27% increase from 2021.